Treatment strategies for tics in Tourette syndrome

  title={Treatment strategies for tics in Tourette syndrome},
  author={Clare M. Eddy and Hugh Edward Rickards and Andrea Eugenio Cavanna},
  journal={Therapeutic Advances in Neurological Disorders},
  pages={25 - 45}
Tourette syndrome (TS) is a chronic neurodevelopmental disorder characterized by tics: repetitive, involuntary movements and vocalizations. These symptoms can have a significant impact on patients’ daily functioning across many domains. Tics tend to be most severe in child and adolescent sufferers, so their presence has the potential to impact a period of life that is both critical for learning and is often associated with the experience of greater social tension and self-consciousness than… 

Tables from this paper

The pharmacology of Tourette syndrome

The recent publication of the European and Canadian guidelines on the management of TS are based on experts’ consensus and highlight the need for randomised controlled trials, especially with regards to newly developed pharmacological agents.

Gilles de la Tourette syndrome

Fits, Tantrums, and Rages in TS and Related Disorders

This paper provides an update on aggressive symptoms in TS with focus on explosive outbursts or “rages” and self-injurious behaviors and the role of psychosocial influences.

Tourette Syndrome and Consciousness of Action

The simultaneous presence of both voluntary and involuntary aspects in the expression of tic symptoms by patients with TS is consistent with the hypothesis that tics can have the same neurophysiologic substrate as voluntary acts, even though they are misperceived as being involuntary.

Update on the role of antipsychotics in the treatment of Tourette syndrome

The present review aims to summarize the current and evidence-based knowledge on the risk-benefit ratio of both first and second generation neuroleptics in TS.

Antiepileptic drugs and Tourette syndrome.

Trials of Pharmacological Interventions for Tourette Syndrome: A Systematic Review

The alpha-2 agonist Clonidine is amongst the agents with the most favourable efficacy-versus-adverse events ratio, especially in patients with co-morbid attention-deficit hyperactivity disorder, although effect sizes vary evidence-based studies.

A case of severe oral self-injurious Tourette's syndrome alleviated by pregabalin.




Case series on the use of aripiprazole for Tourette syndrome.

A retrospective chart review of six youth with TS and comorbid obsessive–compulsive disorder (OCD) who were treated for 12 wk with aripiprazole shows value for treating neuropsychiatric disorders in children.

Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.

Guanfacine may provide a safe alternative therapy for children with ADHD in the presence of tics, and future double-blind, controlled trials should be undertaken.

Aripiprazole for the treatment of Tourette's disorder.

Aripiprazole, a newer atypical antipsychotic with a unique pharmacodynamic profile, appears to be efficacious in treatment of tics in Tourette's disorder, thus impressing upon the need for placebo-controlled trials in the management of this neuropsychiatric syndrome.

The behavioral spectrum of Gilles de la Tourette syndrome.

An updated review of the literature on the multifaceted phenotype of Tourette's syndrome is provided, with special attention to the behavioral problems and the relationship between Tourette’s syndrome and comorbid neuropsychiatric conditions.

[Aripiprazole for the treatment of Tourette syndrome. Experience in 10 patients].

Aripiprazole may be a good pharmacological option for patients with Tourette syndrome and shows a significant response assessed by the Yale severity tics rating scale and the clinical global impression scale.

Clinical Effectiveness of Quetiapine in Children and Adolescents with Tourette’s Syndrome

Other than causing mild weight gain, quetiapine appears to be an effective, safe and well tolerated drug in children and adolescents with Tourette’s syndrome.

Contemporary assessment and pharmacotherapy of Tourette syndrome

Aripiprazole in a case presenting with tourette syndrome and obsessive-compulsive disorder.

The inconsistency in the demonstration of beneficial effects in TS and predominantly OCD and the variability in the dosages needed to obtain a therapeutic effect highlight the necessity of double-blind studies investigating the therapeutic efficacy of aripiprazole.

Electroconvulsive Therapy in a Patient with Tourette's Syndrome and Co-morbid Obsessive Compulsive Disorder

A 39-yearold female patient, who has chronically suffered from both TS and OCD, is presented, who after a course of nine electroconvulsive treatments, her symptomatology resolved fairly rapidly and remission of both disorders has been maintained successfully for more than a year.

Clonidine and haloperidol in Gilles de la Tourette syndrome.

Clinical experience with clonidine hydrochloride as an alternative to haloperidol for the treatment of Gilles de la Tourette syndrome is described, and several issues raised in this article warrant discussion.